跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
KEPPRA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/5ML - PPB Drug Approval Details
Approvals
/
PPB
/
KEPPRA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/5ML
Approved
STANDARD
KEPPRA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/5ML
GLAXOSMITHKLINE LIMITED
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
a15abc0a766c53bc
Company
GLAXOSMITHKLINE LIMITED
Type
Standard
Approval Details
Approval Id
a15abc0a766c53bc
Product Name
KEPPRA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/5ML
Drug Hk Name
KEPPRA CONCENTRATE FOR SOLUTION FOR INFUSION 500MG/5ML
Registration Code
HK-58176
Company Name
GLAXOSMITHKLINE LIMITED
Company Detail Path
/organization/glaxosmithkline
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2009-07-28
Company Address
FLAT/RM 04-10, 10/F, TOWER 6, THE GATEWAY, 9 CANTON ROAD, TSIM SHA TSUI, KOWLOON
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
a15abc0a766c53bc
Type
Standard
Back to PPB Approvals